OTUB2 and cancer: We demonstrated that OTUB2-IN-1 reduced PD-L1 protein turnover through inhibition of OTUB2 catalytic activity rather than blocking the OTUB2-PD-L1 interactions and exhibited strong growth-suppressive effects on multiple cancers by attenuating immunosuppression.